Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker

Figure 4

High ABLIM1 suppressed GBM growth in vivo. (a) The mice weight was recorded since the date of subcutaneous tumor cell injection, showing no statistically significant difference between vector and ABLIM1 groups. (b) Subcutaneous tumor growth was monitored weekly after tumor cell injection according to the tumor volume. The tumor volume was calculated using the formula: ( and ). (c) Four weeks after tumor cell injection, the xenografts were isolated and weighted to compare their differences. (d) Isolated xenografts were photographed, and visual size differences can be observed between vector and ABLIM1 groups. by Student’s -test.

(a)

(b)

(c)

(d)